When it comes to managing weight loss and type 2 diabetes with medications, research shows that it’s out with the old and in with the new. Investigators from Mass General Brigham looked at claims data from nearly 2 million people between 2021 and 2023 and their findings highlight a shifting landscape for weight loss and glucose managing medications. Those changes include a sharp climb in the use of newly approved medications, especially tirzepatide, which is sold under the brand name…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply